Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Mallinckrodt
Baxter
McKinsey
Merck

Last Updated: October 6, 2022

Homatropine methylbromide; hydrocodone bitartrate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for homatropine methylbromide; hydrocodone bitartrate and what is the scope of freedom to operate?

Homatropine methylbromide; hydrocodone bitartrate is the generic ingredient in five branded drugs marketed by Genus, Abhai Llc, Actavis Mid Atlantic, Akorn, Ivax Sub Teva Pharms, Nostrum Labs Inc, Novel Labs Inc, Padagis Us, Torrent, Wockhardt Bio Ag, Halsey, Actavis Elizabeth, Avanthi Inc, and King Pharms, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

Ten suppliers are listed for this compound.

Summary for homatropine methylbromide; hydrocodone bitartrate
Pharmacology for homatropine methylbromide; hydrocodone bitartrate
Drug ClassOpioid Agonist
Mechanism of Action Opioid Agonists

US Patents and Regulatory Information for homatropine methylbromide; hydrocodone bitartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Padagis Us HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 205731-001 Feb 15, 2017 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Avanthi Inc HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 207176-001 Aug 7, 2017 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ivax Sub Teva Pharms HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 040285-001 Jul 19, 1999 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Abhai Llc HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 207487-001 Feb 21, 2017 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
King Pharms TUSSIGON homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 088508-001 Jul 30, 1985 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Torrent HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 204765-001 Mar 6, 2017 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Baxter
McKinsey
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.